Published in Medical Letter on the CDC and FDA, April 3rd, 2005
"The study purpose was to investigate the association of human papillomavirus (HPV) infection with prostate cancer. The presence and type of HPV DNA were investigated by polymerase chain reaction in the preservation fluid of 60 consecutive prostate core biopsies (29 benign, 31 malignant).
"The material was inadequate (no DNA found at P-globin testing) in four benign and five cancer biopsies," scientists writing in the International Journal of Biological Markers report.
"HPV DNA was found in 17 of 26 (65.3%) cancer and 12 of 25...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA